Advertisement

Sedation and Analgesia

  • Richard L. Lambert
  • Lela W. Brink
  • Frank A. Maffei
Chapter

Abstract

Significant pain and anxiety often accompanies many forms of critical illness. The physiologic stress induced by pain and agitation can impede recovery and the delivery of critical care. Additionally, sedation of children may be required to maintain invasive devices often necessary for the monitoring and care of the critically ill or injured child. A thorough understanding of pain physiology and drug pharmacology is necessary to provide analgesia and anxiolysis.

Keywords

Respiratory Depression Biliary Atresia Inactive Metabolite Opioid Withdrawal Procedural Sedation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Ambuel B, Hamlet KW, Marx CM, et al. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol. 1992;17:95–109.PubMedCrossRefGoogle Scholar
  2. American Academy of Pediatrics. Committee on drugs. Neonatal drug withdrawal. Pediatrics. 1998;101:1079–88.Google Scholar
  3. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96(4):1004–17.CrossRefGoogle Scholar
  4. Anand KJ, Willson DF, Berger J, Harrison R, Meert KL, Zimmerman J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5):e1208–25. Epub Apr 19, 2010.PubMedCrossRefGoogle Scholar
  5. Aneja R, Heard AM, et al. Sedation monitoring of children by the bispectral index in the pediatric intensive care unit. Pediatr Crit Care Med. 2003;4:60–4.PubMedCrossRefGoogle Scholar
  6. Barbi E, et al. Deep sedation with propofol by non-anesthesiologists. Arch Pediatr Adolesc Med. 2003;157:1097–1103.PubMedCrossRefGoogle Scholar
  7. Bar-Joseph G, et al. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009;4:40–6.PubMedCrossRefGoogle Scholar
  8. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med. 2002;347:1094–1103.PubMedCrossRefGoogle Scholar
  9. Courman SP, et al. Comparison of bispectral index monitor with the comfort score in assessing level of sedation of critically ill children. Intensive Care Med. 2003;29:2239–46.CrossRefGoogle Scholar
  10. Cravero JP, et al. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: report from the pediatric sedation research consortium. Pediatrics. 2006;118(3):1087–96.PubMedCrossRefGoogle Scholar
  11. Detriche O, et al. The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth. 1999;83:698–701.PubMedGoogle Scholar
  12. Deutshc ES, Nadkarni VM. Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg. 1996;122:1234–8.CrossRefGoogle Scholar
  13. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009;25(3):431–49. vii. Review.PubMedCrossRefGoogle Scholar
  14. Franck LS, et al. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004;20: 344–51.PubMedCrossRefGoogle Scholar
  15. Franck LS, et al. The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008;9(6):573–80.PubMedCrossRefGoogle Scholar
  16. Hatch DJ. Propofol-infusion syndrome in children. Lancet. 1999;353:1117–8.PubMedCrossRefGoogle Scholar
  17. Ista E, van Dijk M, de Hoog M, Tibboel D, Duivenvoorden HJ. Construction of the Sophia observation withdrawal symptoms-scale (SOS) for critically ill children. Intensive Care Med. 2009;35:1075–81.PubMedCrossRefGoogle Scholar
  18. Lambert RL, Freeman AL, Maffei FA. Safety of propofol sedation in children with food allergy. SCCM annual congress. Feb 4-8, 2012, Houston, TX. (SCCM abstract no. 833). Crit Care Med. 2011;39(12)(Supplement):234.PubMedCrossRefGoogle Scholar
  19. Maxwell LG, et al. The effects of a small dose naloxone infusion on opioid induced side effects and analgesia in children and adolescents treated with intravenous patient controlled analgesia: a double blind, prospective, randomized, controlled study. Anesth Analg. 2005;100:953–8.PubMedCrossRefGoogle Scholar
  20. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg. 2003;96(4): 1054–5.PubMedCrossRefGoogle Scholar
  21. Nahata MC. Safety of “inert” additives or excipients in paediatric medicines. Arch Dis Child Fetal Neonatal Ed. 2009;94(6): F392–3.PubMedCrossRefGoogle Scholar
  22. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin. 2009;25(3):451–69. vii.PubMedCrossRefGoogle Scholar
  23. Pate MF, Steelman R. Questions unanswered: propofol use in the pediatric intensive care unit. AACN Adv Crit Care. 2007;18(3):248–52. Review.PubMedCrossRefGoogle Scholar
  24. Reich DL, Sivay G. Ketamine: an update on the first twenty five years of clinical experience. Can J Anaesth. 1989;36:189.CrossRefGoogle Scholar
  25. Reves JG, et al. Midazolam: pharmacology and uses. Anesthesiology. 1985;62:310–7.PubMedCrossRefGoogle Scholar
  26. Rutman MS. Sedation for emergent diagnostic imaging studies in pediatric patients. Curr Opin Pediatr. 2009;21(3):306–12.PubMedCrossRefGoogle Scholar
  27. Secgin S, et al. Determination of difficult intubation in the ED. Am J Emerg Med. 2009;27(8):905–10.CrossRefGoogle Scholar
  28. Shehab N, et al. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med. 2009;10(2):256–9.PubMedCrossRefGoogle Scholar
  29. Shukry M, Miller JA. Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures. Ther Clin Risk Manag. 2010;6:111–21.PubMedCrossRefGoogle Scholar
  30. Siddappa R, et al. Methadone dosage for prevention of opioid withdrawal in children. Paediatr Anaesth. 2003;13:805–10.PubMedCrossRefGoogle Scholar
  31. Spagrud LJ, et al. Children’s self report of pain intensity. Am J Nurs. 2003;103:62–4.PubMedCrossRefGoogle Scholar
  32. Tobias JD. Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use. Paediatr Drugs. 1999;1(2): 109–26.PubMedCrossRefGoogle Scholar
  33. Tobias JD. Tolerance, withdrawal, and physical dependency after long term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28:2122–32.PubMedCrossRefGoogle Scholar
  34. Tunik M, Treiber M, Karpeles T, Kim J, Cooper A, Foltin G. Teaching Resource for Instructors in Prehospital Pediatrics (TRIPP BLS), 2nd Edition, Center for Pediatric Emergency Medicine, CD, HRSA, 2006.Google Scholar
  35. Vespasiano M, et al. Propofol sedation: intensivist’s experience with 7304 cases in a children’s hospital. Pediatrics. 2007;120(2): 1411–7.CrossRefGoogle Scholar
  36. Wilson KC, et al. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005;128(3): 1674–81.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Richard L. Lambert
    • 1
  • Lela W. Brink
    • 1
  • Frank A. Maffei
    • 1
  1. 1.Pediatric Critical Care Medicine, Department of Pediatrics, Geisinger Medical CenterTemple University School of Medicine, Janet Weis Children’s HospitalDanvilleUSA

Personalised recommendations